FDA Considering Charging Fees for Inclusion on Certified Export Lists
The FDA is considering charging fees for including firms on its export lists, which help give foreign governments and other parties information about whether a U.S. food export meets FDA standards or other U.S. regulations. Although the agency doesn’t currently charge firms to be included on export lists for human food, it said Nov. 8 it’s considering charging fees “to offset our costs.”
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
Under the Federal Food, Drug, and Cosmetic Act, the FDA said it can collect up to $175 per certification for each company and its human food products that FDA “certifies through inclusion” on an export list. The agency is seeking public comments on this fee and whether exporters “have any specific suggestions about how FDA should approach the implementation of fees.” It also asked whether listed firms “experience any challenges” seeking a renewal and wants companies to “describe any challenges you have experienced with exporting human food products included on the export lists.”
Comments are due Jan. 7.